Catégorie : Prix/récompenses

Prix de recherche conjoint – Maladies rares du péritoine

Nazim Benzerdjeb 2025

Funding. General coordinator of the multicenter IMMUNORARE5 platform with 5 phase II trials with in 5 rare cancers, investigator-initiated trial in collaboration with Gilead: 2 M€

European Grant. Coordinator of the European project SALVOVAR: A European Multi-Disciplinary Clinical Project Meant To Improve The Management Of Patients With Poor Prognostic Ovarian Cancer After Neoadjuvant Chemotherapy: Restoring Hope, Salvaging Lives: 7 M€

Bonus. For supervision of research and PhD (PEDR)

Grant. NIRAPK study. Ligue contre le cancer: 40,000 euros

Funding. Early phase trial CLIP2, Institut National du Cancer. IMMUNOGAST: An umbrella phase 2 trial to assess personalized targeted IMMUNOtherapy-based regimens in recurrent advanced/metastatic GASTric adenocarcinoma patients. Amount: 500,000 euros.

Funding. TROPHAMET: a phase II trial with safety run-in of Avelumab and METhotrexate in low-risk gestational TROPHoblastic neoplasia as first line treatment. Amount: 800,000 euros.

Funding. ONCOPRO: Predictive value of progastrin titer at diagnosis and of progastrin kinetics during treatment in cancer patients. Amount: 1.6 Millions Euros